Production (Stage)
Lipocine Inc.
LPCN
$3.17
$0.0481.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 93.90K | 3.49M | -- | 89.60K | 7.62M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 93.90K | 3.49M | -- | 89.60K | 7.62M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 93.90K | 3.49M | -- | 89.60K | 7.62M |
| SG&A Expenses | 1.12M | 873.10K | 1.05M | 1.51M | 1.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.18M | 1.95M | 2.63M | 3.38M | 4.39M |
| Operating Income | -2.09M | 1.55M | -2.63M | -3.29M | 3.22M |
| Income Before Tax | -1.86M | 1.78M | -2.22M | -3.07M | 3.51M |
| Income Tax Expenses | 200.00 | 0.00 | -- | 500.00 | 200.00 |
| Earnings from Continuing Operations | -1.86M | 1.78M | -2.22M | -3.07M | 3.51M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.86M | 1.78M | -2.22M | -3.07M | 3.51M |
| EBIT | -2.09M | 1.55M | -2.63M | -3.29M | 3.22M |
| EBITDA | -2.07M | 1.56M | -2.62M | -3.28M | 3.23M |
| EPS Basic | -0.35 | 0.33 | -0.41 | -0.57 | 0.66 |
| Normalized Basic EPS | -0.22 | 0.21 | -0.26 | -0.36 | 0.41 |
| EPS Diluted | -0.35 | 0.31 | -0.44 | -0.57 | 0.66 |
| Normalized Diluted EPS | -0.22 | 0.20 | -0.26 | -0.36 | 0.41 |
| Average Basic Shares Outstanding | 5.35M | 5.35M | 5.35M | 5.34M | 5.32M |
| Average Diluted Shares Outstanding | 5.35M | 5.68M | 5.35M | 5.34M | 5.36M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |